Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
taliglucerase alfa (elelyso) (7 trials)
agalsidase alfa (Replagal) (1 trial)
agalsidase beta (Fabrazyme) (1 trial)
pegunigalsidase alfa (Elfabrio) (10 trials)
dnase (2 trials)
oprx-106 (2 trials)
prx-112 (2 trials)
alglucerase (ceredase) (1 trial)
prx-105 (1 trial)
prx-115 (1 trial)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Cystic Fibrosis (Phase 2)
Fabry Disease (Phase 3)
Fibrosis (Phase 2)
Gaucher Disease (Phase 4)
Ulcer (Phase 2)
Trials (26 total)
Trial APIs (10 total)